For all the observations on the changes in prostate tissues affected by estrogens as well as the associated risk of cancer, relatively little is known about the exact mechanisms by which these ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Based on phase 3 trial findings, investigators conclude that transdermal estradiol should be a standard of care ADT option for patients with nonmetastatic prostate cancer. Transdermal estradiol (tE2) ...

Prostate-specific antigen (PSA) testing may not accurately pinpoint levels at which transgender women on estrogen therapy may be at risk of developing prostate cancer, according to data from the ...

NEW YORK (Reuters Health) - A patch that delivers estrogen through the skin may prove useful in treating advanced cases of prostate cancer, preliminary research suggests. In a study of 13 prostate ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

CaP: Prostate cancer; DPN: Diarylpropionitrile; E: Estradiol 17b; ER: Estrogen receptor; GPR: G-protein-coupled receptor; MPP: Methyl-piperidino-pyrazole; PC ...